Cargando…
Cost‐Effectiveness of Clopidogrel‐Aspirin Versus Aspirin Alone for Acute Transient Ischemic Attack and Minor Stroke
BACKGROUND: Treatment with the combination of clopidogrel and aspirin taken soon after a transient ischemic attack (TIA) or minor stroke was shown to reduce the 90‐day risk of stroke in a large trial in China, but the cost‐effectiveness is unknown. This study sought to estimate the cost‐effectivenes...
Autores principales: | Pan, Yuesong, Wang, Anxin, Liu, Gaifen, Zhao, Xingquan, Meng, Xia, Zhao, Kun, Liu, Liping, Wang, Chunxue, Johnston, S. Claiborne, Wang, Yilong, Wang, Yongjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309076/ https://www.ncbi.nlm.nih.gov/pubmed/24904018 http://dx.doi.org/10.1161/JAHA.114.000912 |
Ejemplares similares
-
Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack
por: Li, Zixiao, et al.
Publicado: (2016) -
Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial
por: Wang, Yilong, et al.
Publicado: (2019) -
Clopidogrel Plus Aspirin in Patients With Different Types of Single Small Subcortical Infarction
por: Wang, Guangyao, et al.
Publicado: (2021) -
Combined impact of body mass index and glycemic control on the efficacy of clopidogrel-aspirin therapy in patients with minor stroke or transient ischemic attack
por: Chen, Zimo, et al.
Publicado: (2020) -
Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Randomized Clinical Trial
por: Xie, Xuewei, et al.
Publicado: (2023)